Clinical trial testing programs

High-quality, next-generation sequencing for efficient clinical trial execution

Clinical trial testing programs

High-quality, next-generation sequencing for efficient clinical trial execution

Invitae has extensive experience supporting biopharmaceutical companies in bringing new therapies to market, faster.

We have a comprehensive test menu that enables the rapid creation of custom genetic testing programs for clinical trials. Our high-quality, next-generation sequencing (NGS)-based diagnostic testing with customized bioinformatics enables efficient execution of global clinical trials. We offer:

  • rapid molecular confirmation to determine patients' clinical trial eligibility

  • extensive experience working with biopharma companies, CROs, principal investigators, and clinical trial sites

  • streamlined logistics infrastructure for global sample collection and one of the broadest test menus in the industry

  • board-certified genetic counselors trained in medical genetics available to assist clinicians

Programs have a custom test requisition form that is tailored specifically to the needs of the trial

Choose from hundreds of curated panels or select specific genes to meet trial needs

Results reported within 10-21 calendar days, on average. STAT results are delivered in as few as 5 days

Clinical Laboratory Improvement Amendments (CLIA) certified, College of American Pathologists (CAP) accredited, and New York Department of Health approved labs